Skip to navigation Skip to content

Severe aplastic anaemia Program in Pharmaceutical Benefits Scheme (PBS) 012-24041212

Expand/Collapse all sectionsExpand all


This document outlines details of PBS-subsidised eltrombopag for patients with severe aplastic anaemia.

Severe aplastic anaemia and listing dates

Severe aplastic anaemia is a rare but serious blood condition in which the bone marrow fails to produce enough new blood cells.

Listing dates: eltrombopag - 1 May 2024.

See Written Authority Required Drugs, for more details.

Enquiries

Transfer enquiries about prescription arrangements to PBS Complex Drugs Programs and choose the option relevant to the condition treated.

The Resources page contains:

  • application forms
  • contact details
  • restriction and item codes
  • the PBS schedule
  • Services Australia website link
  • FAQs from Service Officers

Online Pharmaceutical Benefits Scheme (PBS) Authorities System (OPA System)

Process telephone Authority approval application

Processing and National Demand Allocation (PaNDA)

Processing Complex Authority Required Listings

Processing written authority approval requests

Written Authority Required Drugs